Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B
- 1 May 2012
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 10 (5), 520-526
- https://doi.org/10.1016/j.cgh.2012.01.019
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Management of Chronic Hepatitis B in Asian AmericansDigestive Diseases and Sciences, 2011
- Chronic hepatitis B: Update 2009Journal of Hepatology, 2009
- 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis BGastroenterology, 2009
- Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled studyJournal of Viral Hepatitis, 2009
- Hepatitis B and pregnancy: an underestimated issueLiver International, 2009
- Telbivudine: a new option for the treatment of chronic hepatitis BExpert Opinion on Biological Therapy, 2007
- TelbivudineNature Reviews Drug Discovery, 2007
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An UpdateClinical Gastroenterology and Hepatology, 2006
- Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infectionJournal of Viral Hepatitis, 2003